The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying ...

MAGA Gov. Glenn Youngkin has, for a second straight year, vetoed legislation that would establish a Prescription Drug ...

Me's drugs and patents — including two possible deals — could be key to its exit out of Chapter 11 bankruptcy protection.

Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...

Reports hint that the administration will likely omit industry-specific tariffs from its announcement April 2.

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

Jim Cramer, host of Mad Money, expressed his frustration on March 19 about how investors often get caught up in discussions ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...

Impending U.S. tariffs could have a deep impact on the Irish economy and its strong reliance on pharmaceuticals and digital.

With 23andMe officially up for sale, there’s no telling who might end up owning the company — or what they’ll want with the ...